| Date | Time | Source | Headline | Symbol | Company |
| 07/23/2012 | 9:30AM | Zacks | Earnings Preview: Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/23/2012 | 9:30AM | Zacks | Earnings Preview: Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/18/2012 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/18/2012 | 5:15PM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/17/2012 | 5:18PM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/17/2012 | 5:14PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/17/2012 | 2:10PM | Zacks | TPG to Acquire Par Pharma for $1.9B - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/12/2012 | 3:05PM | Dow Jones News | UPDATE: Icahn Appeals to Nonmanagement Directors at Forest Labs | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/11/2012 | 6:10PM | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/11/2012 | 1:03PM | Zacks | Bristol-Myers/AMLN Deal Progresses - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/10/2012 | 12:01PM | PR Newswire (US) | Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/10/2012 | 8:06AM | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/10/2012 | 7:30AM | Business Wire | Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/10/2012 | 5:15AM | Zacks | Alkermes Upped to Outperform - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/09/2012 | 12:51PM | PR Newswire (US) | Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/07/2012 | 9:00AM | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/06/2012 | 8:53AM | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 9:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 7:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 3:43PM | PR Newswire (US) | Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 10:27AM | Business Wire | Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 6:03AM | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 6:03AM | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 6:03AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/03/2012 | 5:06AM | Zacks | Company News for July 3, 2012 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/02/2012 | 4:57PM | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/02/2012 | 4:56PM | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/02/2012 | 12:23PM | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/02/2012 | 11:55AM | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/02/2012 | 11:53AM | Dow Jones News | Bristol Sees Commercial Muscle Accelerating Sales of Bydureon | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |